Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion type Assertion NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_head.
- NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_provenance.
- NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion evidence source_evidence_literature NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_provenance.
- NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion SIO_000772 14585279 NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_provenance.
- NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion wasDerivedFrom befree-20140225 NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_provenance.
- NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_assertion wasGeneratedBy ECO_0000203 NP886644.RAmfBySIIKZ3fygD0SWB9pMZ8Fc_3RXmayICLQMqZF23Y130_provenance.